DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and ...

With funding from the National Institutes of Health, a Johns Hopkins team led by neuroscience Professor Alex Kolodkin is ...

Advancements in polymer science are transforming the retinal disease treatment landscape, addressing clinical challenges such ...

Researchers suggest people taking Ozempic and similar drugs may face double the risk of developing wet age-related macular ...

Triangle gains public company with merger Breakthrough! RTP biotech sees progress in restoring vision to blind Breakthrough!

New research has found that the endothelial cell-specific A disintegrin and metalloproteinase domain-containing protein 10 ...

When Armando Ernesto Chau straps on the futuristic smart glasses that a young Mozambican robotics student is developing in ...

A combination of genetics and drinking instant coffee is linked to an increased risk of developing a common form of ...

A new study reveals that increasing levels of apolipoprotein M (ApoM) may slow or prevent the progression of age-related macular degeneration (AMD), a major cause of blindness in older adults.

In an office at the Massachusetts Institute of Technology Computer Science and Artificial Intelligence Laboratory, or MIT ...

VisAbility Pittsburgh is a place where people who have lost their vision, or never had vision, learn life skills.

New research has found that the endothelial cell-specific A disintegrin and metalloproteinase domain-containing protein 10 ...